Get with the guidelines for cardiovascular secondary prevention: pilot results
about
Organization of care for acute myocardial infarction in rural and urban hospitals in KansasIschaemic symptoms, quality of care and mortality during myocardial infarctionA novel family-based intervention trial to improve heart health: FIT Heart: results of a randomized controlled trial.Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events.Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data.Contribution of patient and physician factors to cardiac rehabilitation referral: a prospective multilevel study.Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.Physician and patient influences on provider performance: β-blockers in postmyocardial infarction management in the MI-Plus study.Bone quality: educational tools for patients, physicians, and educators.Temporal trends of system of care for STEMI: insights from the Jakarta Cardiovascular Care Unit Network System.Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalizationAdherence to statin treatment following a myocardial infarction: an Italian population-based survey.Effects of cardiac rehabilitation referral strategies on referral and enrollment ratesInfluence of education and working background on physicians' knowledge of secondary prevention guidelines for coronary heart disease: results from a survey in China.The role of systematic inpatient cardiac rehabilitation referral in increasing equitable access and utilization.Chronically critically ill patients: health-related quality of life and resource use after a disease management intervention.The role of hospitalists in the management of acute decompensated heart failure.Present and future of secondary prevention after an acute coronary syndrome.Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes.Quality of care for myocardial infarction in rural and urban hospitals.Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitationLong-term adherence to evidence based secondary prevention therapies after acute myocardial infarction.Optimal approach to improving trauma triage decisions: a cost-effectiveness analysis.Improving the management of acute coronary syndromes in Australia: translating evidence to outcomes.Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.History Bias, Study Design, and the Unfulfilled Promise of Pay-for-Performance Policies in Health Care.Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality MeasuresExamining the effect of a patient navigation intervention on outpatient cardiac rehabilitation awareness and enrollmentExpanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes.Long-term medication adherence after myocardial infarction: experience of a communityContinuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition.Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure.Appropriate secondary prevention of acute atherothrombotic events and strategies to improve guideline adherence.The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program.Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry.Using a standardized follow-up program to improve coronary heart disease secondary prevention.Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.
P2860
Q28210434-F97B2DD6-041A-490B-9BC3-FBF05B712BCBQ28218595-3EA6BBE4-47A7-4D67-9015-C7B9AE462B98Q33572497-A74B8972-4FE2-4A2C-A6D6-E1A098C88EACQ33764415-E499D510-82E1-4F72-AC3A-5D823CBFF520Q33850977-61EA689D-CF76-463C-B1EF-316CF4A1EC28Q33858023-F7DCA765-627B-4FFB-A5DE-1240A4D3C6C5Q34110665-C38BAD9A-212A-497A-AEF6-54725C2D5E21Q34631709-6C889418-210C-4B2A-BF62-E45A1756D131Q34997242-17A6B86E-1E93-44B9-A95A-D66AAF91416BQ35078751-CAC3DAE0-44D3-47EC-83B8-7BF3BCA53B4CQ35092590-E7919A07-0FA3-4D2B-804D-5CE51538DEC5Q35629747-2FAB3EB0-AB54-4BC4-B476-E951F42A072EQ35687652-A6F3EF64-9A91-4DF9-95C8-FB4E2E3B3C39Q35761338-0B360A14-4C9B-46E3-8B20-FFE447DE2F45Q35810154-1F9A672E-538D-420E-A14C-A402E109F548Q35867801-38731E05-8B38-4E23-B7F8-CE22A2A666F9Q36088399-3BB20B24-C55B-4E2A-BA4C-F724DEBD1E96Q36110466-17A8CDDE-28AC-49B5-8645-95443CF7E4F4Q36118008-060C7333-18D9-4BC0-A053-0B234F803AE1Q36160606-10AEFD5F-B63A-497A-A761-5C5EF337330FQ36183620-C95DB637-AA0D-4C27-AC5C-1813732595BDQ36593261-B9555AF4-C32A-4CDD-9786-F74AB06D13D4Q36607183-745C2778-1874-49F4-8428-DDEE32C2875AQ36677427-2422447B-6EC5-452E-803E-62AA3DDE7E0BQ36834441-0E12F858-7F74-48B7-811A-5B649F725695Q36892804-C61819F5-1D8F-4CF6-9239-CFA8189ECEE7Q37052695-9C590CEB-DA71-4C34-AA4D-7D67671DBF66Q37085456-56524FF5-0CE5-4474-8BBC-13B7F9117E99Q37138494-8EC65E64-9600-4A3D-B400-CEE6A06E85E5Q37148386-AC387628-C77E-4C80-B13B-DF826851130BQ37151458-1246756E-70DE-4B20-BF16-9E2D9956C00DQ37166857-23E79D87-2349-4E5B-92C1-CDF80C2A446EQ37226395-481C2DF4-1E55-4B67-A515-F2E3CCE9E5D7Q37328699-92113F55-5853-483B-88EF-E4517E7F1189Q37380499-A749B0AA-38AF-4372-BE24-D7DBDEFEC6BAQ37380507-0B1BB229-2E38-4968-BDBE-32AE8CDD53ABQ37383851-DC6BAF3B-CECE-4C49-9176-7C27E898C3A5Q37434741-34DB8E57-C02C-4800-8DB2-CB88B9B33A9EQ37680291-5A44EDE6-C6F3-4C14-8E86-31880A08307FQ37879071-97C0C56F-FA82-4C25-9A01-A9E8519B504D
P2860
Get with the guidelines for cardiovascular secondary prevention: pilot results
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Get with the guidelines for cardiovascular secondary prevention: pilot results
@ast
Get with the guidelines for cardiovascular secondary prevention: pilot results
@en
Get with the guidelines for cardiovascular secondary prevention: pilot results
@nl
type
label
Get with the guidelines for cardiovascular secondary prevention: pilot results
@ast
Get with the guidelines for cardiovascular secondary prevention: pilot results
@en
Get with the guidelines for cardiovascular secondary prevention: pilot results
@nl
prefLabel
Get with the guidelines for cardiovascular secondary prevention: pilot results
@ast
Get with the guidelines for cardiovascular secondary prevention: pilot results
@en
Get with the guidelines for cardiovascular secondary prevention: pilot results
@nl
P2093
P3181
P1476
Get with the guidelines for cardiovascular secondary prevention: pilot results
@en
P2093
A Gray Ellrodt
James Liljestrand
Kenneth A LaBresh
Randolph Peto
Richard Gliklich
P3181
P356
10.1001/ARCHINTE.164.2.203
P407
P577
2004-01-26T00:00:00Z